SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Jul-24 1:15 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jul-24 | Sale | 405 | $22.93 | $9,286.65 | (< 1%) 71.88K to 71.47K | |
05-Mar-24 4:10 PM View: | Intellia Therapeutics, Inc. (NTLA) | 04-Mar-24 | Sale | 605 | $32.99 | $19,959.00 | (< 1%) 72.08K to 71.47K | |
05-Mar-24 4:10 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-24 | Grant | 31,230 | -- | -- | 76% 40.84K to 72.08K | |
05-Jan-24 4:44 PM View: | Intellia Therapeutics, Inc. (NTLA) | 03-Jan-24 | Sale | 4,608 | $29.50 | $135,954.00 | (10%) 45.45K to 40.84K | |
06-Jul-23 3:34 PM View: | Intellia Therapeutics, Inc. (NTLA) | 03-Jul-23 | Sale | 360 | $40.51 | $14,583.60 | (< 1%) 45.51K to 45.15K | |
22-Jun-23 5:52 PM View: | Intellia Therapeutics, Inc. (NTLA) | 20-Jun-23 | Option Exercise | 5,000 | $12.27 | $61,350.00 | 11% 45.15K to 50.15K | |
22-Jun-23 5:52 PM View: | Intellia Therapeutics, Inc. (NTLA) | 20-Jun-23 | Planned Option Sale | 5,000 | $45.00 | $225,000.00 | (10%) 50.15K to 45.15K | |
03-Mar-23 5:12 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-23 | Grant | 30,673 | -- | -- | 212% 14.47K to 45.15K | |
06-Jan-23 5:21 PM View: | Intellia Therapeutics, Inc. (NTLA) | 04-Jan-23 | Sale | 1,692 | $37.21 | $62,959.30 | (10%) 16.16K to 14.47K | |
06-Jan-23 5:21 PM View: | Intellia Therapeutics, Inc. (NTLA) | 03-Jan-23 | Sale | 231 | $34.48 | $7,964.88 | (1%) 16.4K to 16.16K | |
06-Jan-23 5:21 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Jul-22 | Sale | 105 | $51.74 | $5,432.70 | (< 1%) 16.27K to 16.16K | |
07-Mar-22 7:19 PM View: | Intellia Therapeutics, Inc. (NTLA) | 01-Mar-22 | Grant | 10,527 | -- | -- | 187% 5.64K to 16.16K |